CYTOGENETIC EVOLUTION OF MYCN AND MDM2 AMPLIFICATION IN THE NEUROBLASTOMA LS TUMOR AND ITS CELL-LINE

Citation
R. Corvi et al., CYTOGENETIC EVOLUTION OF MYCN AND MDM2 AMPLIFICATION IN THE NEUROBLASTOMA LS TUMOR AND ITS CELL-LINE, European journal of cancer, 31A(4), 1995, pp. 520-523
Citations number
27
Categorie Soggetti
Oncology
Journal title
ISSN journal
09598049
Volume
31A
Issue
4
Year of publication
1995
Pages
520 - 523
Database
ISI
SICI code
0959-8049(1995)31A:4<520:CEOMAM>2.0.ZU;2-X
Abstract
Amplification of the MYCN gene is frequently seen either in extrachrom osomal double minutes (DMs) or in homogeneously staining regions (HSRs ) of aggressively growing neuroblastomas. Total genomic DNA from cell line LS, from early passages of the same line and from original tumour material was biotinylated and hybridised to metaphase chromosomes of normal human lymphocytes. The reverse genomic hybridisation revealed t he amplified DNA to be derived both from chromosome 2p23-24, which is the position of MYCN, and from chromosome 12 band q13-14. The MDM2 gen e, located at 12q13-14, was found amplified both in early and late pas sages of LS, in addition to amplified MYCN. Amplification units of MYC N and MDM2 appear first to develop within DMs, which then integrate in to different chromosomes to develop to HSRs.